# Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal Cancer

> **NCT00025090** · PHASE3 · COMPLETED · sponsor: **University College London (UCL) Cancer Institute** · enrollment: 600 (estimated)

## Conditions studied

- Anal Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** fluorouracil
- **DRUG:** mitomycin C
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00025090
- **Lead sponsor:** University College London (UCL) Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-03
- **Primary completion:** —
- **Final completion:** 2007-08
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2013-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00025090

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00025090, "Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00025090. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*